We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Endometrial Ablation for Abnormal Uterine Bleeding Associated with High Risk of Hysterectomy

By HospiMedica International staff writers
Posted on 02 Oct 2024

Endometrial ablation (EA) is a minimally invasive procedure used to treat abnormal uterine bleeding (AUB) and is often presented as an alternative to hysterectomy. More...

While EA is generally considered safe with low complication rates, less is understood about the likelihood of patients needing further surgical intervention after the procedure. A recent study has revealed that 29% of individuals who undergo EA will eventually require a hysterectomy to remove the entire uterus within 15 years.

A research group comprising investigators from ICES (Toronto, ON, Canada) conducted an analysis of 76,446 patients over a 15-year period to investigate the need for surgical interventions after an initial EA. The study, published in Facts, Views & Vision in ObGyn, focused on patients who underwent their first EA between 2002 and 2017. The study showed that 22% of these patients required further surgical procedures following their EA. Within the first year, 5% of women proceeded to have a hysterectomy. This rate increased to 17% at five years, 23% at 10 years, and 29% at 15 years. Notably, the rate showed no signs of leveling off even at the 15-year mark. The likelihood of needing a subsequent hysterectomy was higher among younger individuals, those with more complex diagnoses, or those who had previously undergone abdominal surgeries like tubal ligation.

The high percentage of women who ultimately progressed to hysterectomy raises concerns and suggests that EA may be more effective as a short-term solution to improve symptoms, rather than a definitive treatment to prevent hysterectomy, according to the researchers. Additionally, the study found a correlation between surgeon experience and the future risk of surgery following EA. For each additional year of the surgeon's experience (with age used as a proxy), the likelihood of a hysterectomy decreased by 3%. The researchers highlight the potential benefits of combination treatments, such as intrauterine devices (IUDs) or hormone replacement therapies, which may extend the effectiveness of EA and reduce the need for further surgeries, particularly if patients approach menopause. However, they note that more research is needed to explore these treatment options further.

“These results provide valuable information to care providers, who can counsel their patients about more realistic outcomes of endometrial ablation, and the potential need for a future hysterectomy,” said lead author Dr. Jacob McGee, an adjunct scientist at ICES Western.


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
ow Frequency Pulse Massager
ET10 L
New
Radial Artery Compression Device
TR Band
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: New clinical guidance suggests treatments to prevent blood clots in CLTI patients after leg artery procedures (Photo courtesy of Shutterstock)

Stronger Blood Clot Prevention Measures Needed After Leg Artery Procedures in High-Risk Patients

Chronic limb-threatening ischemia (CLTI), the most severe form of peripheral artery disease (PAD), significantly reduces blood flow to the legs and feet. Despite undergoing lower limb revascularization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.